When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
The company is developing a terlipressin-based therapy for the treatment of ascites.
BIVI is a tiny biopharma with little in the way of resources and a long road ahead for treatment approval, so the IPO is ultra-high risk.
Company & Market
Los Angeles, California-based BioVie was founded in 2013 to develop and market new therapies for the treatment of life-threatening chronic liver diseases and associated complications.